Teva Offers EU Concessions Over Allergan Generics Deal

According to Reuters.com, “Teva Pharmaceutical Industries Ltd has offered concessions to allay EU antitrust concerns over its $40.5 billion bid for Allergan’s generics unit which will cement its position as the world’s largest generics...